IP Verse

Md Healthcare competitive analysis

Loading summary...

Latest patents of Md Healthcare opposed by its competitors

Explore Md Healthcare's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3165227
Oct 27, 2021Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila Bacteria1

Latest publications and patents of Md Healthcare New

Explore the latest publications and patents granted to Md Healthcare, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Md Healthcare

EP3165227
Oct 27, 2021Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila BacteriaPatent Maintained As Amended

Latest PTAB cases involving Md Healthcare

Discover the latest PTAB cases involving Md Healthcare, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Md Healthcare with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MD HEALTHCARE - 1 - -
ICOSA EUROPE2 - - -